Yee Mandy, Maal-Bared Geith, Ting-A-Kee Ryan, Chwalek Michal, Mackay-Clackett Isabel, Bergamini Michael, Grieder Taryn E, van der Kooy Derek
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Eur J Neurosci. 2020 Aug;52(3):3074-3086. doi: 10.1111/ejn.14718. Epub 2020 Mar 24.
Caffeine, the most commonly consumed psychoactive drug in the world, is readily available in dietary sources, including soft drinks, chocolate, tea and coffee. However, little is known about the neural substrates that underlie caffeine's rewarding and aversive properties and what ultimately leads us to seek or avoid caffeine consumption. Using male Wistar rats in a place conditioning procedure, we show that systemic caffeine at a low intraperitoneal dose of 2 mg/kg (or 100 µM injected directly into the rostral, but not caudal, portion of the ventral tegmental area) produced conditioned place preferences. By contrast, high doses of systemic caffeine at 10 and 30 mg/kg produced conditioned place aversions. These aversions were not recapitulated by a caffeine analog restricted to the periphery. Both caffeine reward and aversion were blocked by systemic D1-like receptor antagonism using SCH23390, while systemic D2-like receptor antagonism with eticlopride had smaller effects on caffeine motivation. Most important, we demonstrated that pharmacological blockade of dopamine receptors using α-flupenthixol injected into the nucleus accumbens shell, but not core, blocked caffeine-conditioned place preferences. Conversely, α-flupenthixol injected into the nucleus accumbens core, but not shell, blocked caffeine-conditioned place aversions. Thus, our findings reveal two dopamine-dependent and functionally dissociable mechanisms for processing caffeine motivation, which are segregated between nucleus accumbens subregions. These data provide novel evidence for the roles of the nucleus accumbens subregions in mediating approach and avoidance behaviours for caffeine.
咖啡因是世界上最常摄入的精神活性药物,在包括软饮料、巧克力、茶和咖啡在内的饮食来源中很容易获得。然而,对于咖啡因的奖赏和厌恶特性背后的神经基质以及最终导致我们寻求或避免摄入咖啡因的因素,我们知之甚少。在一项位置条件反射实验中,我们使用雄性Wistar大鼠,结果表明,腹腔注射低剂量2毫克/千克的全身咖啡因(或直接注射到腹侧被盖区头侧而非尾侧的100微摩尔咖啡因)会产生条件性位置偏好。相比之下,10毫克/千克和30毫克/千克的高剂量全身咖啡因会产生条件性位置厌恶。仅限于外周的咖啡因类似物不会重现这些厌恶反应。使用SCH23390进行全身D1样受体拮抗可阻断咖啡因的奖赏和厌恶反应,而使用依替必利进行全身D2样受体拮抗对咖啡因动机的影响较小。最重要的是,我们证明,向伏隔核壳部而非核心注射α-氟奋乃静进行多巴胺受体的药理学阻断,可阻断咖啡因条件性位置偏好。相反,向伏隔核核心而非壳部注射α-氟奋乃静可阻断咖啡因条件性位置厌恶。因此,我们的研究结果揭示了两种依赖多巴胺且功能可分离的处理咖啡因动机的机制,它们在伏隔核亚区域之间是分开的。这些数据为伏隔核亚区域在介导对咖啡因的趋近和回避行为中的作用提供了新的证据。